Melinda Halasz

6PUBLICATIONS
15CO-AUTHORS
Predictive and prognostic markersCellular nervous systemMedical molecular engineering of nucleic acids and proteinsSignal transductionMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 25, 2026
MYCN inhibits TrkC-mediated differentiation in neuroblastoma cells via disruption of the PKA signalling pathway.

Stephanie Maher, Andrew Roe, Kieran Wynne

|Oct 10, 2024
A temporal (phospho-)proteomic dataset of neurotrophic receptor tyrosine kinase signalling in neuroblastoma.

Stephanie Maher, Kieran Wynne, Vadim Zhernovkov

|Dec 09, 2023
Epigenetic Dysregulation in MYCN-Amplified Neuroblastoma.

Soraya Epp, Shin Mei Chuah, Melinda Halasz

|Jan 21, 2023
Disease-Gene Networks of Skin Pigmentation Disorders and Reconstruction of Protein-Protein Interaction Networks.

Cian D'Arcy, Olivia Bass, Philipp Junk

|Sep 14, 2022
Control of cell state transitions.

Oleksii S Rukhlenko, Melinda Halasz, Nora Rauch

|Jun 10, 2017
Lapatinib potentiates cytotoxicity of YM155 in neuroblastoma via inhibition of the ABCB1 efflux transporter.

Branka Radic-Sarikas, Melinda Halasz, Kilian V M Huber

Pageof 1

Frequent Collaborators

2 joint publications

Walter Kolch

2 joint publications

Stephanie Maher

1 joint publications

Branka Radic-Sarikas

1 joint publications

Kilian V M Huber